Trimebutine maleate is a multi-target inhibitor and opioid receptor agonist with antimuscarinic activity. It inhibits L-type Ca2+ and large-conductance calcium-activated potassium channels, blocking ion influx and efflux. It also targets Toll-like receptors, suppressing signals and inhibiting LPS-induced IRAK1, ERK1/2, JNK, and NF-κB activation for anti-inflammatory effects. It induces tumor cell apoptosis via AKT/ERK pathway inhibition and prevents excessive smooth muscle contraction, making it useful for gastrointestinal disorder studies.
- Multi-target inhibitor and opioid receptor agonist
- Exhibits antimuscarinic activity
- Blocks calcium influx and potassium ion efflux
- Suppresses Toll-like receptor signals
- Provides anti-inflammatory effects
- Induces tumor cell apoptosis
- Inhibits excessive smooth muscle contraction
- Useful in gastrointestinal disorder research